Dr. Baker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Lurie Children's Hospital - Division of Genetics
225 East Chicago Avenue
Chicago, IL 60611Phone+1 312-227-6120Fax+1 312-227-9413
Summary
- I am a board certified Pediatric Geneticist, specializing in inborn errors of metabolism. Trained in Boston, MA and now making my career in Chicago, IL. I am active in clinical trials, currently focused on those related to PKU and LSDs. Special interest in Healthcare Disparities, particularly how they pertain to genetic testing and metabolism follow up.
Education & Training
- Children's Hospital/Harvard Medical SchoolFellowship, Medical Biochemical Genetics, 2019 - 2020
- Boston Children’s HospitalFellowship, Clinical Biochemical Genetics, 2017 - 2019
- University of Illinois College of Medicine at PeoriaResidency, Pediatrics, 2014 - 2017
- Des Moines University College of Osteopathic MedicineClass of 2014
Certifications & Licensure
- IL State License 2014 - 2026
- MA State License 2017 - 2020
- American Board of Medical Genetics and Genomics Medical Biochemical Genetics
- American Board of Pediatrics Pediatrics
- American Board of Medical Genetics and Genomics Clinical Genetics and Genomics
Publications & Presentations
PubMed
- 8 citationsGenotypic and phenotypic spectrum of infantile liver failure due to pathogenic TRMU variants.Georg F Vogel, Yael Mozer-Glassberg, Yuval E Landau, Lea D Schlieben, Holger Prokisch
Genetics in Medicine. 2023-06-01 - 2 citationsVariable disease manifestations and metabolic management within a single family affected by ornithine transcarbamylase deficiency.Joshua Baker, Lauren Hitchins, Erika Vucko, Kirsten Havens, Karen Becker
Molecular Genetics and Metabolism Reports. 2022-12-01 - 5 citationsPegvaliase dose escalation to 80 mg daily may lead to efficacy in patients who do not exhibit an optimal response at lower doses.Erika R Vucko, Kirsten E Havens, Joshua J Baker, Barbara K Burton
Molecular Genetics and Metabolism Reports. 2022-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: